ATE432926T1 - Oxazolderivate als histamin-h3-rezeptor- wirkstoffe, deren herstellung und therapeutische verwendung - Google Patents
Oxazolderivate als histamin-h3-rezeptor- wirkstoffe, deren herstellung und therapeutische verwendungInfo
- Publication number
- ATE432926T1 ATE432926T1 AT05773290T AT05773290T ATE432926T1 AT E432926 T1 ATE432926 T1 AT E432926T1 AT 05773290 T AT05773290 T AT 05773290T AT 05773290 T AT05773290 T AT 05773290T AT E432926 T1 ATE432926 T1 AT E432926T1
- Authority
- AT
- Austria
- Prior art keywords
- histamine
- nitrogen
- formula
- ring
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US59119104P | 2004-07-26 | 2004-07-26 | |
PCT/US2005/024883 WO2006019833A1 (en) | 2004-07-26 | 2005-07-14 | Oxazole derivatives as histamine h3 receptor agents, preparation and therapeutic uses |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE432926T1 true ATE432926T1 (de) | 2009-06-15 |
Family
ID=35134220
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT05773290T ATE432926T1 (de) | 2004-07-26 | 2005-07-14 | Oxazolderivate als histamin-h3-rezeptor- wirkstoffe, deren herstellung und therapeutische verwendung |
Country Status (17)
Country | Link |
---|---|
US (1) | US7666871B2 (de) |
EP (1) | EP1786790B1 (de) |
JP (1) | JP4982367B2 (de) |
CN (1) | CN1989115B (de) |
AT (1) | ATE432926T1 (de) |
AU (1) | AU2005275183B2 (de) |
BR (1) | BRPI0513777A (de) |
CA (1) | CA2575081C (de) |
CY (1) | CY1109493T1 (de) |
DE (1) | DE602005014786D1 (de) |
DK (1) | DK1786790T3 (de) |
ES (1) | ES2325865T3 (de) |
MX (1) | MX2007001029A (de) |
PL (1) | PL1786790T3 (de) |
PT (1) | PT1786790E (de) |
SI (1) | SI1786790T1 (de) |
WO (1) | WO2006019833A1 (de) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8008301B2 (en) * | 2004-04-01 | 2011-08-30 | Eli Lilly And Company | Histamine H3 receptor agents, preparation and therapeutic uses |
EP1848428A4 (de) | 2005-02-18 | 2012-04-18 | Neurogen Corp | Thiazolamide, imidazolamide und verwandte analoga |
AU2006228690A1 (en) | 2005-03-31 | 2006-10-05 | Ucb Pharma S.A. | Compounds comprising an oxazole or thiazole moiety, processes for making them, and their uses |
PL1954684T3 (pl) | 2005-11-15 | 2014-10-31 | Otsuka Pharma Co Ltd | Związek oksazolowy i kompozycja farmaceutyczna |
BRPI0709612A2 (pt) | 2006-03-15 | 2011-07-19 | Wyeth Corp | composto de fórmula i; método para o tratamento de um distúrbio no sistema nervoso central relacionado ou afetado pelo receptor histamina-3 em um paciente que necessita deste tratamento; método para a inibição do receptor h3; composição farmacêutica; e processo para a preparação de um composto de fórmula i |
CN101432261A (zh) | 2006-05-19 | 2009-05-13 | 惠氏公司 | 作为组织胺-3拮抗剂的n-苯甲酰基-吡咯烷-3-基胺和n-苄基-吡咯烷-3-基胺 |
US20090215628A1 (en) * | 2006-05-19 | 2009-08-27 | Basf Se | Benzoyl-Substituted Alanines |
US8329159B2 (en) * | 2006-08-11 | 2012-12-11 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
PE20081152A1 (es) | 2006-10-06 | 2008-08-10 | Wyeth Corp | Azaciclilaminas n-sustituidas como antagonistas de histamina-3 |
CA2693138A1 (en) * | 2007-07-16 | 2009-01-22 | Wyeth Llc | Aminoalkylazole derivatives as histamine-3 antagonists |
WO2009126782A1 (en) * | 2008-04-11 | 2009-10-15 | High Point Pharmaceuticals, Llc | Histamine h3 receptor ligands |
US8383829B2 (en) * | 2008-04-15 | 2013-02-26 | Konica Minolta Holdings, Inc. | Electrochromic compound, electrode, and display element |
SA110310332B1 (ar) * | 2009-05-01 | 2013-12-10 | Astrazeneca Ab | مركبات ميثانون (3 استبدال -ازيتيدين -1-يل )(5- فينيل -1، 3، 4- أوكساديازول -2-يل ) |
SG186275A1 (en) | 2010-07-06 | 2013-01-30 | Astrazeneca Ab | Therapeutic agents 976 |
UY34194A (es) | 2011-07-15 | 2013-02-28 | Astrazeneca Ab | ?(3-(4-(espiroheterocíclico)metil)fenoxi)azetidin-1-il)(5-(fenil)-1,3,4-oxadiazol-2-il)metanona en el tratamiento de la obesidad? |
WO2013151982A1 (en) | 2012-04-03 | 2013-10-10 | Arena Pharmaceuticals, Inc. | Methods and compounds useful in treating pruritus, and methods for identifying such compounds |
AU2014208964B2 (en) | 2013-01-23 | 2016-09-01 | Astrazeneca Ab | Chemical compounds |
US9845291B2 (en) | 2014-12-18 | 2017-12-19 | Genentech, Inc. | Estrogen receptor modulators and uses thereof |
MA41562B1 (fr) | 2015-06-03 | 2019-05-31 | Bristol Myers Squibb Co | Agonistes d'apj 4-hydroxy-3-(heteroaryl)pyridine-2-one a utiliser dans le traitement de troubles cardio-vasculaires |
PL3319959T3 (pl) | 2015-07-06 | 2022-02-14 | Alkermes, Inc. | Hetero-haloinhibitory deacetylazy histonowej |
EP3319968A1 (de) | 2015-07-06 | 2018-05-16 | Rodin Therapeutics, Inc. | Heterobicyclische n-aminophenyl-amide als inhibitoren der histondeacetylase |
WO2018132533A1 (en) | 2017-01-11 | 2018-07-19 | Rodin Therapeutics, Inc. | Bicyclic inhibitors of histone deacetylase |
SI3664802T1 (sl) | 2017-08-07 | 2022-10-28 | Alkermes, Inc. | Biciklični zaviralci histon deacetilaze |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3819037A1 (de) * | 1988-06-04 | 1989-12-14 | Hoechst Ag | 2,4-disubstituierte oxazol-derivate, verfahren zu ihrer herstellung sowie ihre verwendung als therapiemittel gegen krankheiten, die durch rhinoviren verursacht werden |
KR100196356B1 (ko) * | 1993-09-28 | 1999-06-15 | 오스카 아끼히꼬 | 당뇨병 치료제 |
AU3957600A (en) * | 1999-04-26 | 2000-11-10 | Boehringer Ingelheim International Gmbh | Piperidyl-imidazole derivatives, their preparations and therapeutic uses |
AU2002254114A1 (en) | 2001-03-23 | 2002-10-08 | Eli Lilly And Company | Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses |
CN1625554A (zh) | 2002-02-01 | 2005-06-08 | 诺沃挪第克公司 | 氨基烷基-取代的氮杂环丁烷、吡咯烷、哌啶与氮杂环庚烷的酰胺 |
DE10259244A1 (de) * | 2002-12-17 | 2004-07-01 | Merck Patent Gmbh | N-(Indolethyl-)cycloamin-Verbindungen |
US7332508B2 (en) | 2002-12-18 | 2008-02-19 | Novo Nordisk A/S | Substituted homopiperidine, piperidine or pyrrolidine derivatives |
US7259262B2 (en) * | 2003-10-24 | 2007-08-21 | Hoffmann-La Roche Inc. | Arylazole derivatives, their manufacture and use as pharmaceutical agents |
-
2005
- 2005-07-14 CN CN200580024874XA patent/CN1989115B/zh not_active Expired - Fee Related
- 2005-07-14 CA CA2575081A patent/CA2575081C/en not_active Expired - Fee Related
- 2005-07-14 AU AU2005275183A patent/AU2005275183B2/en not_active Ceased
- 2005-07-14 BR BRPI0513777-2A patent/BRPI0513777A/pt not_active IP Right Cessation
- 2005-07-14 ES ES05773290T patent/ES2325865T3/es active Active
- 2005-07-14 DK DK05773290T patent/DK1786790T3/da active
- 2005-07-14 EP EP05773290A patent/EP1786790B1/de not_active Not-in-force
- 2005-07-14 DE DE602005014786T patent/DE602005014786D1/de active Active
- 2005-07-14 PT PT05773290T patent/PT1786790E/pt unknown
- 2005-07-14 MX MX2007001029A patent/MX2007001029A/es active IP Right Grant
- 2005-07-14 JP JP2007523605A patent/JP4982367B2/ja not_active Expired - Fee Related
- 2005-07-14 US US11/572,283 patent/US7666871B2/en not_active Expired - Fee Related
- 2005-07-14 WO PCT/US2005/024883 patent/WO2006019833A1/en active Application Filing
- 2005-07-14 PL PL05773290T patent/PL1786790T3/pl unknown
- 2005-07-14 AT AT05773290T patent/ATE432926T1/de active
- 2005-07-14 SI SI200530741T patent/SI1786790T1/sl unknown
-
2009
- 2009-08-06 CY CY20091100831T patent/CY1109493T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
AU2005275183A1 (en) | 2006-02-23 |
CY1109493T1 (el) | 2014-08-13 |
DK1786790T3 (da) | 2009-07-20 |
PL1786790T3 (pl) | 2009-10-30 |
EP1786790B1 (de) | 2009-06-03 |
AU2005275183B2 (en) | 2011-03-17 |
WO2006019833A1 (en) | 2006-02-23 |
CN1989115B (zh) | 2012-03-21 |
MX2007001029A (es) | 2007-04-12 |
JP4982367B2 (ja) | 2012-07-25 |
CA2575081A1 (en) | 2006-02-23 |
ES2325865T3 (es) | 2009-09-22 |
PT1786790E (pt) | 2009-08-18 |
JP2008507579A (ja) | 2008-03-13 |
SI1786790T1 (sl) | 2009-10-31 |
US7666871B2 (en) | 2010-02-23 |
DE602005014786D1 (de) | 2009-07-16 |
EP1786790A1 (de) | 2007-05-23 |
CA2575081C (en) | 2013-05-07 |
BRPI0513777A (pt) | 2008-05-13 |
CN1989115A (zh) | 2007-06-27 |
US20070197604A1 (en) | 2007-08-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE432926T1 (de) | Oxazolderivate als histamin-h3-rezeptor- wirkstoffe, deren herstellung und therapeutische verwendung | |
TWI262917B (en) | 2-Furancarboxylic hydrazides and pharmaceutical compositions containing the same | |
NZ627750A (en) | Carbamate compounds and of making and using same | |
ATE454372T1 (de) | Am histamin-h3-rezeptor wirksame mittel, herstellung und therapeutische anwendungen | |
ATE537830T1 (de) | Nicotinamid derivate und ihre verwendung als therapeutika | |
ECSP055633A (es) | Nuevos derivados de benzoimidazolutiles como angentes antiproliferativos | |
RS51137B (sr) | Derivat benzimidazola i njegova upotreba kao antagonista receptora aii | |
TW200716528A (en) | Cyclopropanecarboxamide derivatives | |
ATE445609T1 (de) | Substituierte thiophenderivate als glucagonrezeptorantagonisten, herstellung und therapeutische anwendungen | |
NO20064065L (no) | Diaminopyrimidiner som P2X3 og P2X2/3 antagonister | |
IS8503A (is) | Azatvíhringja heteróhringir sem kannabínóníð-viðtakastillar | |
RU2006147307A (ru) | Производные 3-карбамоил-2-пиридона | |
ECSP024393A (es) | Derivados biciclicos sustituidos para el tratamiento del crecimiento celular normal | |
MX2007008614A (es) | Peptidos con actividad agonista del receptor del neuropeptido-2 (y2r). | |
BRPI0506765A (pt) | composto ou um seu sal, hidrato e/ou pró-droga farmaceuticamente aceitáveis, composição farmacêutica, métodos para inibir a produção de beta-amilóide em um paciente e para tratar de uma doença, kit farmacêutico, uso de um composto ou de uma composição | |
EA200970705A1 (ru) | Новые фармацевтические композиции | |
PE20071177A1 (es) | Derivados de 3,5-piridina como inhibidores de renina | |
ATE325796T1 (de) | Derivate von triazolyl-imidazopyridine und von triazolylpurine als ligande des adenosine a2a rezeptoren und ihre verwendung als medicamente | |
MX2007005709A (es) | Compuestos de n-sulfonilaminobencil-2-fenoxiacetamida sustituidos. | |
GB0701366D0 (en) | Novel pharmaceutical compositions | |
DE602005021150D1 (de) | 3-substituierte pyridinderivate als h3-antagonisten | |
ECSP088829A (es) | Derivados de bencimidazol 5-sulfonamida como ligandos del receptor cannabinoide 1 (cb1) | |
PE20060273A1 (es) | Derivados de tetrahidroisoquinolilsulfonamidas como moduladores del receptor h3 | |
JP2010513489A5 (de) | ||
ES2197003A1 (es) | Nuevos compuestos antagonistas de integrinas alfa. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1786790 Country of ref document: EP |